Marginal Zone Lymphoma(MZL)

Explore clinical trials studying Marginal Zone Lymphoma(MZL). Study availability and eligibility vary by location and protocol.

14 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Marginal Zone Lymphoma(MZL) trial results

Enrolling by invitation

NCT07173790

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +32 more
Locations: Samsung Medical Center Seoul, Gangnam-gu, South Korea

Korea UniversityKorea University Guro Hospital Seoul, Guro-gu, South Korea

Seoul National University Hospital Seoul, Jongno-gu, South Korea

The Catholic University of Korea Seoul, Seocho-gu, South Korea

Active, not recruiting

NCT07480863

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, beijing, Beijing, China

Active, not recruiting

NCT07247383

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations: 2ndAffiliated Hospital, School of Medicine, Zhejiang University, China Hangzhou, Zhejiang, China

Completed

NCT06782854

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +30 more
Locations: IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy